Luo X - Search Results

1

Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy.

Furman WL, Rodman JH, Tonda ME, Luo X, Arnold B, Marina N, Garrison L, Hanna R, Pratt CB, Meyer WH. Furman WL, et al. Among authors: luo x. Cancer Chemother Pharmacol. 1998;41(3):229-36. doi: 10.1007/s002800050733. Cancer Chemother Pharmacol. 1998. PMID: 9443640 Clinical Trial.

2

Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience.

Pratt CB, Luo X, Fang L, Marina N, Avery L, Furman WL. Pratt CB, et al. Among authors: luo x. Med Pediatr Oncol. 1996 Sep;27(3):145-8. doi: 10.1002/(SICI)1096-911X(199609)27:3<145::AID-MPO2>3.0.CO;2-E. Med Pediatr Oncol. 1996. PMID: 8699990 Clinical Trial.

3

Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors.

Furman WL, Luo X, Fairclough D, Garrison L, Marina N, Pratt CB, Bleyer A, Meyer WH. Furman WL, et al. Among authors: luo x. Med Pediatr Oncol. 1997 Jun;28(6):444-50. doi: 10.1002/(sici)1096-911x(199706)28:6<444::aid-mpo10>3.0.co;2-9. Med Pediatr Oncol. 1997. PMID: 9143391 Clinical Trial.

4

Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site.

Pratt CB, Meyer WH, Rao BN, Pappo AS, Fleming ID, Luo X, Cain A, Kaste SC, Shearer PD, Jenkins JJ 3rd. Pratt CB, et al. Among authors: luo x. Cancer. 1997 Sep 15;80(6):1171-7. Cancer. 1997. PMID: 9305720

5

Second malignant neoplasms occuring in survivors of osteosarcoma.

Pratt CB, Meyer WH, Luo X, Cain AM, Kaste SC, Pappo AS, Rao BN, Fleming ID, Jenkins JJ 3rd. Pratt CB, et al. Among authors: luo x. Cancer. 1997 Sep 1;80(5):960-5. doi: 10.1002/(sici)1097-0142(19970901)80:5<960::aid-cncr19>3.0.co;2-u. Cancer. 1997. PMID: 9307198

6

Comparison of cytokines in children with recurrent solid tumors treated with intensive chemotherapy.

Furman WL, Luo X, Marina N, Garrison L, Pratt CB, Meyer WH. Furman WL, et al. Among authors: luo x. J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):62-8. doi: 10.1097/00043426-199801000-00010. J Pediatr Hematol Oncol. 1998. PMID: 9482415

7

A phase I study of sulofenur in refractory pediatric malignant solid tumors.

Pratt CB, Bowman LC, Marina N, Pappo A, Avery L, Luo X, Meyer WH. Pratt CB, et al. Among authors: luo x. Invest New Drugs. 1995;13(1):63-6. doi: 10.1007/BF02614222. Invest New Drugs. 1995. PMID: 7499110 Clinical Trial.

8

Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.

Beaty O 3rd, Hudson MM, Greenwald C, Luo X, Fang L, Wilimas JA, Thompson EI, Kun LE, Pratt CB. Beaty O 3rd, et al. Among authors: luo x. J Clin Oncol. 1995 Mar;13(3):603-9. doi: 10.1200/JCO.1995.13.3.603. J Clin Oncol. 1995. PMID: 7884422

9

Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients.

Pappo AS, Parham DM, Cain A, Luo X, Bowman LC, Furman WL, Rao BN, Pratt CB. Pappo AS, et al. Among authors: luo x. Med Pediatr Oncol. 1996 Feb;26(2):81-4. doi: 10.1002/(SICI)1096-911X(199602)26:2<81::AID-MPO2>3.0.CO;2-Q. Med Pediatr Oncol. 1996. PMID: 8531857

10

Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992.

Sandoval C, Meyer WH, Parham DM, Kun LE, Hustu HO, Luo X, Pratt CB. Sandoval C, et al. Among authors: luo x. Med Pediatr Oncol. 1996 Mar;26(3):180-5. doi: 10.1002/(SICI)1096-911X(199603)26:3<180::AID-MPO6>3.0.CO;2-G. Med Pediatr Oncol. 1996. PMID: 8544800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,046 results

Search Page

Filters